SOP Guide for Pharma

Analytical Method Development: SOP for Use of Certified Reference Standards – V 2.0

Analytical Method Development: SOP for Use of Certified Reference Standards – V 2.0

Standard Operating Procedure for Use of Certified Reference Standards in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/385/2025
Supersedes SOP/AMD/385/2022
Page No. Page 1 of 13
Issue Date 01/06/2025
Effective Date 04/06/2025
Review Date 01/06/2027

1. Purpose

To define a standardized procedure for the procurement, qualification, handling, storage, and use of Certified Reference Standards (CRS) in the Analytical Method Development department to ensure data accuracy, reliability, and regulatory compliance.

2. Scope

This SOP

applies to all certified reference standards used in the development, qualification, and validation of analytical methods for APIs and drug products. It includes reference materials procured from pharmacopoeias (e.g., USP, EP), commercial vendors, or in-house developed working standards.

3. Responsibilities

  • Analytical Chemist: Responsible for receipt, verification, and proper handling of CRSs.
  • Store Coordinator: Maintains inventory and storage records of CRSs.
  • Quality Assurance: Reviews CRS qualification documents and approves in-house reference standards.
  • AMD Manager: Ensures compliance with SOP and regulatory expectations.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring the availability, qualification, traceability, and appropriate usage of CRSs in method development and validation.

5. Procedure

5.1 Procurement of Certified Reference Standards

  1. Procure CRS from official sources (e.g., USP, EP, BP) or qualified vendors with traceability documentation and CoA (Certificate of Analysis).
  2. Document vendor approval and purchase justification (Annexure-1).

5.2 Receipt and Verification

  1. Inspect CRS packaging upon receipt for integrity, labeling, and compliance with purchase order.
  2. Verify the following:
    • Product name and catalog number
    • Batch number and expiration date
    • Storage conditions
    • CoA traceability and lot-specific data
  3. Record the CRS in the inventory register (Annexure-2).

5.3 Storage Conditions

  • Store CRSs as per manufacturer’s recommendations (e.g., 2–8°C for light-sensitive compounds).
  • Use desiccators, refrigeration units, or light-protective containers as required.
  • Ensure temperature and humidity monitoring logs are maintained daily.

5.4 Qualification of In-House Reference Standards

  1. When CRS is not available, prepare a primary working standard (PWS) using a validated lot of API.
  2. Compare analytical results of PWS with available pharmacopeial or certified standards.
  3. Evaluate purity by chromatographic methods, moisture by Karl Fischer, and calculate correction factors.
  4. Prepare a qualification report and submit to QA for approval (Annexure-3).

5.5 Usage and Documentation

  1. Label all standard containers with:
    • Substance name and batch number
    • Date of opening and expiry
    • Storage condition and user initials
  2. Record usage in the CRS usage logbook (Annexure-4).
  3. Do not reuse containers once expired or contaminated.

5.6 Retesting and Re-qualification

  • For CRSs without expiry date, perform retesting at defined intervals (e.g., annually) based on stability data.
  • Document retest results and extend validity upon QA approval only.

5.7 Disposal

  • Expired or rejected standards must be labeled ‘To Be Discarded’ and moved to the designated rejection area.
  • Dispose of according to SOP on hazardous chemical disposal (refer to SOP/QA/054/2025).

6. Abbreviations

  • CRS: Certified Reference Standard
  • CoA: Certificate of Analysis
  • PWS: Primary Working Standard
  • QA: Quality Assurance
  • SOP: Standard Operating Procedure

7. Documents

  1. Annexure-1: CRS Purchase and Verification Form
  2. Annexure-2: CRS Inventory Register
  3. Annexure-3: In-House Qualification Report Format
  4. Annexure-4: CRS Usage Logbook

8. References

  • ICH Q6A – Specifications: Test Procedures and Acceptance Criteria
  • Pharmacopoeial standards (USP, EP, BP)
  • 21 CFR Part 211.84 – Testing and Approval or Rejection of Components

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Vaibhav Singh Reema Pillai Dr. Harshita Goyal
Designation Analytical Chemist QA Reviewer Head – AMD
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: CRS Purchase and Verification Form

Product Name Catalog No. Vendor Batch No. Expiry Checked By
Caffeine CRS USP-1101 USP CRS-1098 2026-09 Reema Pillai

Annexure-2: CRS Inventory Register

Sr. No. Name Batch No. Opened On Expiry Status
1 Paracetamol CRS PCRS-1001 01/05/2025 31/05/2026 Active

Annexure-3: In-House Qualification Report Format

Report No.: AMD/IHQS/385/2025
Substance: Metformin Working Standard
Purity: 99.78% (by HPLC)
Moisture Content: 0.5%
Correction Factor: 0.994
Approved By: QA Manager

Annexure-4: CRS Usage Logbook

Date User Standard Batch No. Purpose Remarks
01/06/2025 V. Singh Aspirin CRS ASP-789 Assay Calibration Standard weighed and diluted

Revision History

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Expanded qualification and storage guidelines Annual review Dr. Harshita Goyal
02/05/2022 1.0 Initial version New SOP QA Head
Exit mobile version